GPBAR1 activation affects energy expenditure [12], glucose metabolism, and insulin sensitivity [13]; thus, the exogenous modulation of the receptor representing an attractive strategy to treat metabolic disorders [6,14,15,16]. This evidence concerns the gene GPBAR1 and metabolic disease.